These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 28595442

  • 1. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC, Raman S, Wan BA, da Silva JLP, Moraes FY, Lima KMLB, Silva MF, Diz MDPE, Chow E, Marta GN.
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [Abstract] [Full Text] [Related]

  • 2. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):e337-42. PubMed ID: 22763028
    [Abstract] [Full Text] [Related]

  • 3. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Radiother Oncol; 2016 May 01; 119(2):208-12. PubMed ID: 27157890
    [Abstract] [Full Text] [Related]

  • 4. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N, Wilke J, Reschke D, Kaiser F, Schmoor C, Grugel R, Boller E.
    J Med Econ; 2018 Sep 01; 21(9):920-929. PubMed ID: 29874105
    [Abstract] [Full Text] [Related]

  • 5. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A, Zeng L, Nguyen J, Zhang L, Jon F, Dennis K, Holden L, Culleton S, Koo K, Tsao M, Barnes E, Danjoux C, Sahgal A, Simmons C, Chow E.
    Clin Oncol (R Coll Radiol); 2012 Mar 01; 24(2):125-33. PubMed ID: 21917431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
    Kurosaka S, Satoh T, Chow E, Asano Y, Tabata K, Kimura M, Tsumura H, Matsumoto K, Ishiyama H, Inoue Y, Hayakawa K, Baba S.
    Ann Nucl Med; 2012 Jul 01; 26(6):485-91. PubMed ID: 22477263
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr 01; 12(2):213-9. PubMed ID: 22458622
    [Abstract] [Full Text] [Related]

  • 13. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L, Chow E, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bedard G, Bottomley A.
    Support Care Cancer; 2012 Dec 01; 20(12):3307-13. PubMed ID: 22562607
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Quality of Life Using EORTC QLQ-BM22 in Patients with Bone Metastases after Treatment with Magnetic Resonance Guided Focused Ultrasound.
    Chen ZQ, Wang CR, Ma XJ, Sun W, Shen JK, Sun MX, Fu ZZ, Hua YQ, Cai ZD.
    Orthop Surg; 2018 Aug 01; 10(3):264-271. PubMed ID: 30019516
    [Abstract] [Full Text] [Related]

  • 15. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
    Chow S, Ding K, Wan BA, Brundage M, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Chow E.
    Am J Hosp Palliat Care; 2018 Apr 01; 35(4):718-723. PubMed ID: 28950727
    [Abstract] [Full Text] [Related]

  • 16. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A, European Organization for Research Treatment of Cancer Quality of Life Group.
    Cancer; 2012 Mar 01; 118(5):1457-65. PubMed ID: 21837676
    [Abstract] [Full Text] [Related]

  • 17. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar R, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Support Care Cancer; 2016 Dec 01; 24(12):4871-4878. PubMed ID: 27465049
    [Abstract] [Full Text] [Related]

  • 18. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
    Yeh DC, Chen DR, Chao TY, Chen SC, Wang HC, Rau KM, Feng YH, Chang YC, Lee KD, Ou-Yang F, Kuo WH, Chang KJ, Lin YC, Tseng LM, Hou MF.
    In Vivo; 2014 Dec 01; 28(5):1001-4. PubMed ID: 25189922
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
    Chow S, Ding K, Wan BA, Brundage M, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Chow E.
    Ann Palliat Med; 2017 Dec 01; 6(Suppl 2):S185-S194. PubMed ID: 29156903
    [Abstract] [Full Text] [Related]

  • 20. Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study.
    Cacicedo J, Ciria JP, Morillo V, Martinez-Indart L, Gómez-Iturriaga A, Del Hoyo O, Büchser D, Frias A, San Miguel I, Suarez F, Casquero F.
    J Med Imaging Radiat Oncol; 2020 Dec 01; 64(6):859-865. PubMed ID: 32729219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.